ArticleApplied biochemistry and biotechnology2026
Hyaluronic Acid Increase Anti-Inflammatory and Regenerative Effects of Adipose-Derived Mesenchymal Stem Cells in an Interstitial Cystitis Rat Model.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To study the effects of pre-treating adipose-derived mesenchymal stem cells (ADMSCs) with hyaluronic acid (HA) in a rat model of interstitial cystitis (IC). Fifty female rats were dividing into 5 groups: Sham treatment, IC, HA, ADMSCs, and HA-preconditioned ADMSCs. No treatments were administered in the sham and IC groups. Two weeks after treatment, rats were sacrificed and samples of blood and bladder tissue were collected for gene expression analysis, flow cytometry, histopathology and immunohistochemical staining. Preconditioning of ADMSCs with HA led to downregulation in inflammatory markers including tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6). The HA-preconditioned ADMSCs group showed significant reduction in T-lymphocyte markers (CD4, CD3/Pd-1and Pdl-1) and natural killer cell marker (CD56) positive cells (P < 0.001). The histological examination showed regenerated urothelium in the HA-preconditioned ADMSCs group. Preconditioning ADMSCs with HA greatly improves their anti-inflammatory and regenerative properties in experimental IC. This integrated therapy approach holds potential as a prospective cell-based intervention for IC.
Indexed as
Identifiers
41989669What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.